SCHEMBL995325

SCHEMBL995325

COc1cncc(-c2ccc3ncc4c(c3c2)n(-c2cccc(C)c2)c(=O)n4C)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 13/20 0.62
▸ MTOR P42345 13/20 0.62
▸ PIK3CA P42336 10/20 0.62
▸ PIK3CB P42338 8/20 0.62
▸ PIK3CG P48736 8/20 0.62
▸ ATM Q13315 6/20 0.47
▸ ATR Q13535 6/20 0.47
▸ PIK3C2A O00443 2/20 0.47
▸ PIK3C2B O00750 2/20 0.47
▸ PIK3C3 Q8NEB9 2/20 0.47
▸ CHEK1 O14757 1/20 0.47
▸ ABCB11 O95342 1/20 0.47
▸ CSF1R P07333 1/20 0.47
▸ MET P08581 1/20 0.47
▸ PIK3R1 P27986 1/20 0.47
▸ LTK P29376 1/20 0.47
▸ CDK7 P50613 1/20 0.47
▸ NEK2 P51955 1/20 0.47
▸ JAK3 P52333 1/20 0.47
▸ LIMK1 P53667 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2887430 0.86 MTOR (0.57) PIK3CDMTORPIK3CAPIK3CBPIK3CG
SCHEMBL994354 0.85 MTOR (0.61) PIK3CDMTORPIK3CAPIK3CBPIK3CG
SCHEMBL14844887 0.83 MTOR (0.66) PIK3CDMTORPIK3CAPIK3CBPIK3CG
SCHEMBL3515260 0.81 PIK3CD (0.57) PIK3CDMTORPIK3CAPIK3CBPIK3CG
SCHEMBL927455 0.81 MTOR (0.59) PIK3CDMTORPIK3CAPIK3CBPIK3CG
SCHEMBL927144 0.80 PIK3CA (0.72) PIK3CDMTORPIK3CAPIK3CBPIK3CG
SCHEMBL3180388 0.79 MTOR (0.62) PIK3CDMTORPIK3CAPIK3CBPIK3CG
SCHEMBL3180379 0.79 MTOR (0.62) PIK3CDMTORPIK3CAPIK3CBPIK3CG
SCHEMBL929764 0.79 MTOR (0.62) PIK3CDMTORPIK3CAPIK3CBPIK3CG
SCHEMBL14872899 0.78 MTOR (0.51) PIK3CDMTORPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2270008-B1 8-heteroaryl-3-alkyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as PI-3 kinases inhibitors NOVARTIS AG (CH) 2012-10-03 — — EP disclosed
EP-2292617-B1 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors NOVARTIS AG (CH) 2012-07-11 — — EP disclosed
EP-1888578-B9 2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-IMIDAZO [4,5-C] QUINOLINYL)-PHENYL]PROPIONITRILE AS LIPID KINASE INHIBITOR NOVARTIS AG (CH) 2012-04-25 — — EP disclosed
EP-1888578-B1 2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-IMIDAZO [4,5-C] QUINOLINYL)-PHENYL]PROPIONITRILE AS LIPID KINASE INHIBITOR NOVARTIS AG (CH) 2011-11-30 — — EP disclosed
EP-2292617-A1 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors Novartis AG (CH) 2011-03-09 — — EP disclosed
EP-2270008-A1 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinases inhibitors Novartis AG (CH) 2011-01-05 — — EP disclosed
Send feedback